NCT01745848View on ClinicalTrials.gov

Roflumilast on Markers of Bone Metabolism and Endothelial Function in COPD

PHASE4CompletedINTERVENTIONAL
Enrollment

26

Participants

Timeline

Start Date

February 28, 2013

Primary Completion Date

June 30, 2016

Study Completion Date

June 30, 2016

Conditions
Chronic Obstructive Pulmonary Disease
Interventions
DRUG

Roflumilast

Trial Locations (1)

15213

Emphysema COPD Research Center, Pittsburgh

All Listed Sponsors
lead

University of Pittsburgh

OTHER

NCT01745848 - Roflumilast on Markers of Bone Metabolism and Endothelial Function in COPD | Biotech Hunter | Biotech Hunter